Drug Shortage Report for POTASSIUM CHLORIDE INJECTION

Last updated on 2018-08-29 History
Report ID 58038
Drug Identification Number 02241676
Brand name POTASSIUM CHLORIDE INJECTION
Common or Proper name Potassium Chloride 10mmol in 100mL
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 7.46MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 100mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-08-13
Actual start date 2018-08-13
Estimated end date 2018-08-28
Actual end date 2018-08-28
Shortage status Resolved
Updated date 2018-08-29
Company comments Alternative doses of high-concentration potassium chloride are available. Please consult your hospital pharmacy for acceptable clinical alternatives. E.g. 10mmol KCl in 50mL SWI (JB0821P) and 20mmol KCl in 100mL SWI (JB0827P).
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-08-29 French Compare
v4 2018-08-29 English Compare
v3 2018-08-14 English Compare
v2 2018-08-13 French Compare
v1 2018-08-13 English Compare

Showing 1 to 5 of 5